Breaking Down Hubei Feilihua Quartz Glass Co., Ltd. Financial Health: Key Insights for Investors

CN | Basic Materials | Chemicals - Specialty | SHZ

Hubei Feilihua Quartz Glass Co., Ltd. (300395.SZ) Bundle

Get Full Bundle:
$25 $15
$9 $7
$9 $7
$9 $7
$9 $7
$9 $7
$9 $7
$9 $7
$9 $7

TOTAL:

Curious whether Hubei Feilihua Quartz Glass Co., Ltd. (300395.SZ) is a growth story or an overvalued specialty-materials play? The company posted quarterly revenue of 473.68 million CNY for the quarter ending September 30, 2025 (up 18.82% quarter-on-quarter) while trailing twelve‑month revenue sits at 1.81 billion CNY (down 5.22% YoY) after a 2024 full-year revenue of 1.74 billion CNY (down 16.68%); profitability shows a TTM net profit of 413.29 million CNY (EPS 0.79 CNY) with a profit margin of 19.67% and operating margin of 23.11%, and H1 2025 net profit jumped to 220 million CNY (+28.7%), supported by a gross margin improving to 49.2% and net margin to 23.0%; balance sheet and liquidity read conservatively strong with cash & equivalents of 1.75 billion CNY, total debt of 440.59 million CNY (net cash ≈ 1.31 billion CNY), a debt-to-equity of 0.08, current ratio 3.89 and quick ratio 2.74, while operating cash flow surged to 190 million CNY in H1 2025 (versus 10 million CNY prior) though free cash flow to OCF is -2.07 and cash conversion cycle is 60 days; market pricing is rich-market cap 44.18 billion CNY, share price 86.82 CNY (Dec 15, 2025), trailing P/E 106.50, forward P/E 85.44, P/S 26.69 and P/B 7.80 with EV/EBITDA of 54.04 and EV/Revenue 15.27 (beta -0.09); key operational metrics include revenue per employee ~720,166 CNY across 2,513 staff and an interest coverage of 29.99; watch risks from raw material price swings, regulatory shifts in semiconductors/aerospace, competitive tech advances and subsidiary expansion, balanced against growth levers such as R&D rising 12% to 250 million CNY in 2024, new ultra-thin quartz product trails, aerospace order recovery, 18 high-performance composite projects, and management's profit projections of 576 million CNY, 845 million CNY and 1.09 billion CNY for 2025-2027-read on to unpack valuation nuances, cash dynamics and the scenarios that matter most to investors

Hubei Feilihua Quartz Glass Co., Ltd. (300395.SZ) - Revenue Analysis

Key top-line figures and trends for Hubei Feilihua Quartz Glass Co., Ltd. through the latest reported periods:

Metric Value Period / Note
Quarterly Revenue 473.68 million CNY Quarter ending Sep 30, 2025; +18.82% QoQ
Trailing Twelve Months (TTM) Revenue 1.81 billion CNY -5.22% YoY
Annual Revenue (2024) 1.74 billion CNY -16.68% vs. 2023
Revenue per Employee 720,166 CNY Based on 2,513 employees
Price-to-Sales (P/S) Ratio 26.69 Market valuation
Market Capitalization 44.18 billion CNY As of Dec 15, 2025
Share Price 86.82 CNY As of Dec 15, 2025
  • The quarter ending Sep 30, 2025 shows a strong sequential recovery (+18.82% QoQ), indicating recent demand or operational improvement.
  • TTM revenue down 5.22% YoY signals that the quarterly uptick has not fully offset earlier declines over the past 12 months.
  • Annual 2024 revenue contracted 16.68% vs. 2023, pointing to a material revenue pressure during the prior fiscal year.

Interpretation of valuation and productivity metrics:

  • A P/S ratio of 26.69 implies the market is pricing significant growth or premium margins into the stock relative to current sales; investors should weigh this against recent revenue declines.
  • Revenue per employee (~720k CNY) provides a productivity benchmark-useful when comparing peers in specialty glass and materials sectors.
  • Market cap of 44.18 billion CNY at an 86.82 CNY share price contextualizes scale versus absolute revenue (TTM 1.81B CNY).

Quick reference: further company background and historical context available at Hubei Feilihua Quartz Glass Co., Ltd.: History, Ownership, Mission, How It Works & Makes Money

Hubei Feilihua Quartz Glass Co., Ltd. (300395.SZ) - Profitability Metrics

  • Trailing twelve months (TTM) net profit: 413.29 million CNY; EPS: 0.79 CNY
  • Profit margin (TTM): 19.67%
  • Operating margin (TTM): 23.11%
  • Return on assets (ROA): 2.94%
  • Return on equity (ROE): 7.09%
Metric Value Period/Note
Net Profit 413.29 million CNY TTM
EPS 0.79 CNY TTM
Profit Margin 19.67% TTM
Operating Margin 23.11% TTM
ROA 2.94% TTM
ROE 7.09% TTM
H1 2025 Net Profit 220.00 million CNY +28.7% YoY
H1 2025 Gross Profit Margin 49.2% +6.4 percentage points YoY
H1 2025 Net Margin 23.0% +3.1 percentage points YoY
  • H1 2025 performance shows margin expansion driven by higher gross profitability (49.2%) and improved net margin (23.0%), supporting the strong YoY net profit rise of 28.7%.
  • Operating margin (23.11%) exceeding profit margin (19.67%) suggests effective operational leverage but also indicates non-operating costs or tax impacts reducing final net margin.
  • ROE of 7.09% vs ROA of 2.94% reflects leverage contribution to shareholder returns; absolute ROE remains moderate for industrial peers.
Hubei Feilihua Quartz Glass Co., Ltd.: History, Ownership, Mission, How It Works & Makes Money

Hubei Feilihua Quartz Glass Co., Ltd. (300395.SZ) - Debt vs. Equity Structure

Hubei Feilihua Quartz Glass Co., Ltd. (300395.SZ) presents a conservative capital structure with strong short-term liquidity and high interest coverage, while market valuation multiples suggest a premium relative to earnings and revenues.
  • Debt-to-Equity Ratio: 0.08 - very low leverage, equity-funded balance sheet emphasis.
  • Current Ratio: 3.89 - ample ability to meet short-term obligations.
  • Quick Ratio: 2.74 - strong immediate liquidity excluding inventories.
  • Interest Coverage Ratio: 29.99 - robust ability to service interest from operating earnings.
  • EV/EBITDA: 54.04 - high valuation multiple versus operating cashflow proxy.
  • EV/Revenue: 15.27 - market assigns a substantial premium to each unit of revenue.
Metric Value Interpretation
Debt-to-Equity Ratio 0.08 Minimal financial leverage; lower solvency risk
Current Ratio 3.89 Strong short-term liquidity
Quick Ratio 2.74 Liquid assets comfortably cover immediate liabilities
Interest Coverage Ratio 29.99 Operating income >> interest expense
EV/EBITDA 54.04 Market values EBITDA at a high multiple
EV/Revenue 15.27 High revenue multiple - premium pricing by market
Hubei Feilihua's low debt-to-equity (0.08) combined with current and quick ratios (3.89 and 2.74) signal a conservative liquidity posture that reduces refinancing and bankruptcy risk. The interest coverage ratio (29.99) indicates interest obligations are a minor burden relative to operating earnings, lowering solvency concerns even further. However, valuation multiples (EV/EBITDA 54.04; EV/Revenue 15.27) reflect market expectations of significant growth, superior margins, or scarce comparable assets; these high multiples increase sensitivity to any earnings disappointments. Investors should weigh the low financial risk profile against the premium the market currently assigns. For company background and broader context, see: Hubei Feilihua Quartz Glass Co., Ltd.: History, Ownership, Mission, How It Works & Makes Money

Hubei Feilihua Quartz Glass Co., Ltd. (300395.SZ) - Liquidity and Solvency

Hubei Feilihua Quartz Glass Co., Ltd. (300395.SZ) presents a strong short-term liquidity profile underpinned by substantial cash reserves and a net cash position, while capital expenditure dynamics and cash conversion timing introduce areas for monitoring.
  • Cash and cash equivalents: 1.75 billion CNY.
  • Total debt: 440.59 million CNY.
  • Net cash position (Cash - Debt): 1.31 billion CNY.
  • Operating cash flow (1H 2025): 190 million CNY (vs. 10 million CNY in 1H 2024).
  • Operating cash flow / Operating income: 0.54.
  • Free cash flow / Operating cash flow: -2.07.
  • Cash conversion cycle: 60 days.
Metric Value Notes
Cash & equivalents 1,750,000,000 CNY Strong liquidity buffer
Total debt 440,590,000 CNY Low absolute leverage
Net cash 1,309,410,000 CNY Cash minus debt
Operating cash flow (1H 2025) 190,000,000 CNY Significant YoY improvement from 10,000,000 CNY
Op CF / Operating income 0.54 Indicates efficient cash generation
Free CF / Op CF -2.07 CapEx > Op CF, negative free cash flow
Cash conversion cycle 60 days Moderate working capital cycle
  • Implication - Liquidity cushion: With 1.75 billion CNY in cash and a net cash position of ~1.31 billion CNY, the company is well positioned to meet short-term obligations and absorb shocks.
  • Implication - Operational improvement: Operating cash flow rising to 190 million CNY (1H 2025) from 10 million CNY last year demonstrates materially improved conversion of sales to cash (Op CF / Operating income = 0.54).
  • Implication - Investment intensity: Free cash flow to operating cash flow at -2.07 signals that capital expenditures substantially exceed operating cash generation, warranting attention to CapEx plans and returns.
  • Implication - Working capital management: A 60-day cash conversion cycle reflects the time to convert inventory and receivables into cash; combined with ample cash balances, this is manageable but should be tracked against industry peers.
Mission Statement, Vision, & Core Values (2026) of Hubei Feilihua Quartz Glass Co., Ltd.

Hubei Feilihua Quartz Glass Co., Ltd. (300395.SZ) - Valuation Analysis

Hubei Feilihua Quartz Glass Co., Ltd. shows premium market pricing across multiple valuation metrics, signaling elevated investor expectations for future growth and profitability.
  • Trailing P/E: 106.50 - market is paying a high multiple for past earnings, implying expectations of strong future earnings growth or scarce earnings base.
  • Forward P/E: 85.44 - still very high, though modestly lower than trailing, indicating analysts expect earnings to rise but valuation remains stretched.
  • P/B: 7.80 - the stock trades at a substantial premium to book value, reflecting intangible value, growth prospects, or return-on-equity expectations above peers.
  • EV/EBITDA: 54.04 - exceptionally high, suggesting the enterprise value greatly exceeds current operating cash generation.
  • EV/Revenue: 15.27 - market assigns a large multiple to each yuan of revenue, consistent with premium growth expectations.
  • Market Cap: 44.18 billion CNY; Share Price: 86.82 CNY (as of 2025-12-15).
  • Beta: -0.09 - unusually low and slightly negative, indicating price movements have been largely uncorrelated or inversely correlated with the broader market.
Metric Value Implication
Trailing P/E 106.50 High valuation vs. historical earnings; sensitive to EPS changes
Forward P/E 85.44 Elevated expectation for earnings growth
Price-to-Book (P/B) 7.80 Market values assets and intangibles far above book equity
EV/EBITDA 54.04 Very expensive relative to operating cash flow
EV/Revenue 15.27 High revenue multiple; growth is being priced in
Market Capitalization 44.18 billion CNY Sizeable market valuation
Share Price (2025-12-15) 86.82 CNY Reference price for ratios above
Beta -0.09 Low volatility and weak correlation with market
  • Investor considerations: with P/E and EV multiples well above typical industrial and materials peers, valuation sensitivity to earnings disappointments is high; margin improvement, new capacity, or significant margin of safety would be needed to justify current multiples.
  • Risk factors implicit in these multiples include execution risk on growth initiatives, cyclical demand for quartz glass, and potential capital intensity affecting cash conversion.
  • For context on corporate strategy and long-term objectives that may underpin this premium, see: Mission Statement, Vision, & Core Values (2026) of Hubei Feilihua Quartz Glass Co., Ltd.

Hubei Feilihua Quartz Glass Co., Ltd. (300395.SZ) - Risk Factors

  • Raw material price volatility: quartz and specialty silica feedstock account for a material portion of production cost. A simulated sensitivity analysis shows that a 10% rise in raw material input prices could raise COGS by ~4-8% depending on product mix and pass-through ability, compressing gross margin by roughly 2-5 percentage points in short-term scenarios.
  • Regulatory and policy shifts: demand from semiconductor and aerospace customers is highly policy-sensitive. Changes in export controls, domestic incentives, or procurement rules can alter order timing and volumes; scenario modeling indicates that a 15-25% reduction in OEM procurement in a shock could reduce company revenue by a comparable band in affected product lines within 6-12 months.
  • Competitive technology risk: rapid R&D advances by competitors in low-defect quartz or substitute materials can erode pricing power. If competitor technologies capture 10-15% market share in critical niches, price concessions of 3-7% could be required to retain volume, impacting operating margin.
  • Macroeconomic and geopolitical exposure: demand from overseas semiconductor and aerospace hubs drives a portion of sales. An economic downturn or geopolitical disruption reducing external demand by 20% could lower consolidated sales and depress utilization rates, increasing unit fixed cost.
  • Integration and expansion risks: capital injections and capacity builds - e.g., capital increase in subsidiary Zhongyi New Materials - expose the company to execution, timing, and integration risk. Typical risks include 6-18 month lead-time slippage and 5-15% cost overruns versus budget in complex technical projects.
  • Foreign exchange fluctuations: international sales and imported equipment expose earnings to FX swings. A 5% depreciation of RMB vs. USD could increase imported capital-equipment costs by ~5% (one-off capex effect) while improving RMB-reported revenue for USD-priced exports; net P&L impact depends on hedging and currency mix.

Quantitative scenario table (illustrative impact ranges on key financial metrics under adverse shocks):

Risk Scenario Revenue Impact Gross Margin Impact (ppt) Op. Profit Impact Time Horizon
Raw material cost spike (+10%) 0% to -6% -2 to -5 -3% to -10% 0-6 months
Policy-led demand drop (semiconductor/aerospace -20%) -10% to -25% -3 to -8 -8% to -20% 6-12 months
Competitor tech gains (10-15% share) -5% to -12% -1 to -4 -4% to -12% 12-24 months
Geopolitical/export disruption (20% export hit) -8% to -20% -2 to -6 -6% to -18% 6-18 months
Subsidiary expansion overruns (+10% cost) 0% to -3% (near-term) -0.5 to -2 -2% to -6% 0-24 months
FX shock (RMB -5% vs USD) ±0% to +3% (reporting effect) neutral to +1 ±0% to +3% 0-12 months
  • Balance sheet and liquidity considerations: during extended demand weakness or project overruns, leverage and cash burn risk rise. Key metrics investors should monitor include net debt/EBITDA, current ratio, and available undrawn credit lines; stress-testing covenant headroom under the above scenarios is recommended.
  • Mitigants and monitoring points:
    • Raw material sourcing diversification, hedging, and strategic inventory buffers.
    • Customer concentration monitoring and long-term contracts with key semiconductor and aerospace clients.
    • R&D spend pace and patent pipeline tracking versus peer benchmarks to assess competitive technology risk.
    • Clear milestones and independent oversight for Zhongyi New Materials capital projects to limit integration slippage.
    • Currency hedging policies and natural offsets (local sourcing vs. export receipts) to reduce FX P&L volatility.

Further background and company context: Hubei Feilihua Quartz Glass Co., Ltd.: History, Ownership, Mission, How It Works & Makes Money

Hubei Feilihua Quartz Glass Co., Ltd. (300395.SZ) - Growth Opportunities

Hubei Feilihua is positioning itself for multi-year expansion through product innovation, sector diversification and increased R&D investment. Key initiatives and measurable indicators underline potential upside for investors.

  • Ultra-thin quartz electronic cloth: product development advanced - currently in client testing and certification phases with pilot samples undergoing field validation.
  • Aerospace sector expansion: order flows show early signs of recovery, creating pathway to higher-margin, long-term contracts.
  • Composite materials push: 18 high-performance composite structural component projects successfully developed by end-2024, opening new application markets (defense, aerospace, industrial).
  • Industrial chain strategy: continued vertical integration and material-tech breakthroughs aimed at securing supply, reducing costs and protecting margins.
Metric 2024 2025 (proj.) 2026 (proj.) 2027 (proj.)
R&D expense (CNY) 250,000,000 - - -
R&D YoY change +12% - - -
Projected net profit (CNY) - 576,000,000 845,000,000 1,090,000,000
Composite projects completed 18 (end-2024) - - -
  • R&D-led growth: 250 million CNY in R&D (2024) - a 12% increase - supports commercialization of ultra-thin quartz cloth and enhancement of composite offerings.
  • Revenue and margin catalysts: aerospace order recovery and industrial adoption of composites can materially lift top-line and operating margins once certification and scale are achieved.
  • Risk-managed scaling: ongoing certification and client testing reduce go-to-market risk; industrial-chain deepening mitigates raw material volatility.

Further context on shareholder composition, historical performance and investor interest can be reviewed here: Exploring Hubei Feilihua Quartz Glass Co., Ltd. Investor Profile: Who's Buying and Why?

DCF model

Hubei Feilihua Quartz Glass Co., Ltd. (300395.SZ) DCF Excel Template

    5-Year Financial Model

    40+ Charts & Metrics

    DCF & Multiple Valuation

    Free Email Support


Disclaimer

All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.

We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.

All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.